큐로셀
24,400KRWMarket close of 10/27 (Tue)
Up +4.72%+1,100KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)25,000KRWUp +2.46%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 23,250
- High
- 24,900
- Low
- 23,100
- Day range
- Day range low 23,100 high 24,900, open 23,250, close 24,400, previous close 23,300
- Volume
- 3×10K shares
- 711.16 million KRW 0.78× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
8%1-year close range 20,850 to 65,000 won, 8% up from the low
8% of the way up from the lowest close in 1 year (252 sessions) · -62.5% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27Points to check
- Earningsto check-35.4B KRWOperating income over the last four quarters -35.4B KRW (loss)
- Recent filingsnot verifiedCould not read filing data, so not verified
- Daily moveusual range+4.72%+4.72%, 1.5× the usual (20-session average ±3.17%)That day +4.72% · usual ±3.17% · large-move threshold ±6.3%
The other 2 are within the usual range
- Trading value0.8×usual range
- Foreign & institutional+200.00 million KRWusual range
See the full check report
Same sector · 바이오 R&D
Down -0.67%· 26 of 64 stocks up, preferred shares excluded · trading value 190.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.6% | Flat 0.00% | 51.8B KRW |
| 올릭스 | Close over the last 20 sessions -11.8% | Down -5.72% | 24.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -8.3% | Up +0.37% | 14.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -20.9% | Down -1.54% | 12.1B KRW |
| 페니트리움바이오 | Close over the last 20 sessions -4.2% | Up +14.41% | 9.8B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 19 days
- Next data 10/29 (Thu) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.